Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Triple Flag Precious Metals Fourth Quarter 2025 Earnings Call - Record 2025, debt-free with a clear path to 140-150k GEOs by 2030
Triple Flag closed 2025 with record production and cash generation, reporting 113,000 GEOs and operating cash flow per share of $1.54, up 45% year-over-year. Management exited the year debt-free, with...
- Record 2025 production of 113,000 GEOs, the ninth consecutive year-over-year increase.
- Operating cash flow per share was $1.54 in 2025, a 45% increase from 2024; management calls this their single most important metric.
- 2026 guidance: 95,000-105,000 GEOs, based on well-understood mine sequencing and a conservative gold:silver price ratio of 72 for the year.
- +13 more takeaways
Liberty Latin America Q4 & Full Year 2025 Earnings Call - Adjusted OIBDA recovery and strategic rebuilds set stage for 2027 comeback
Liberty Latin America closed 2025 with a clear pivot from damage control to reconstruction and growth. The group reported $1.7 billion of adjusted OIBDA, about 9% rebased growth, while disciplined cap...
- Group adjusted OIBDA reached $1.7 billion for full year 2025, a 9% rebased increase, despite Hurricane Melissa headwinds.
- Adjusted OIBDA less P&E additions surged 27% to $1.1 billion, representing a 24% margin of revenue, driven by cost actions and lower capital intensity.
- LLA added over 225,000 mobile postpaid subscribers in 2025, led by Costa Rica (160k+ postpaid adds) and supported by fixed-mobile convergence and prepaid to postpaid migration.
- +9 more takeaways
Pediatrix Medical Group Q4 2025 Earnings Call - Strong 2025 and $280-300M 2026 EBITDA Guidance, ACA Subsidy Risk Unquantified
Pediatrix closed 2025 with a solid finish, reporting full-year adjusted EBITDA of $276 million and Q4 adjusted EBITDA of $66 million, and it is guiding 2026 to $280 million to $300 million. Management...
- Q4 adjusted EBITDA was $66 million, in line with updated guidance.
- Full-year 2025 adjusted EBITDA was $276 million, described as very strong by management.
- 2026 adjusted EBITDA guidance is $280 million to $300 million, midpoint roughly 5% above 2025.
- +12 more takeaways
N-able Fourth Quarter 2025 Earnings Call - AI and Adlumin Integration Accelerate Upmarket ARR Momentum
N-able closed 2025 with $540 million in ARR and a message: AI is not theoretical, it is the growth engine. Management flagged successful integration of the Adlumin acquisition, meaningful cross-sell, ...
- Exited 2025 with $540 million in ARR, representing 12% year-over-year growth on a reported basis and 8% on a constant currency basis.
- Fourth quarter revenue was $130 million, $3 million above the high end of guidance, with subscription revenue of $129 million.
- Full-year 2025 revenue was $511 million, up ~10% reported and 9% constant currency; subscription revenue was $506 million.
- +16 more takeaways
Avis Budget Group Q4 2025 Earnings Call - Americas demand shock, aggressive fleet defleeting and EV reset drove a ~$150M quarterly miss
Avis Budget Group reported a painful Q4 that missed the October outlook by roughly $150 million, driven almost entirely by the Americas. A sudden November demand whipsaw, prompted by FAA flight reduct...
- Avis reported full-year adjusted EBITDA of $748 million versus an October guide of $900 million, implying about a $150 million fourth quarter shortfall versus guidance.
- The miss was concentrated in the Americas, while international delivered a meaningful turnaround and met expectations in 2025.
- Commercial rental days in the Americas went from modestly down in October to down 11% in November after FAA reductions, air traffic control issues, and extended TSA wait times reduced discretionary travel.
- +12 more takeaways
Mativ Q4 and Full Year 2025 Earnings Call - Record Free Cash Flow and Margin Expansion from Discipline
Mativ closed 2025 with modest organic revenue growth, stronger margins, and a big jump in cash generation after a year of aggressive cost, pricing, and portfolio moves. Q4 sales were $463 million, ful...
- Record free cash flow of $94 million in 2025, more than double 2024, driven by price execution, inventory reduction and expense control.
- Consolidated Adjusted EBITDA rose to $225 million for the year, Q4 Adjusted EBITDA was $53.5 million, up 19% YoY, and consolidated margins improved ~180 basis points vs prior year.
- Net sales were just under $2.0 billion for 2025, up 2.5% organically for the year, Q4 net sales of $463 million were up ~1.9% organically vs prior year.
- +12 more takeaways
Appian Fourth Quarter 2025 Earnings Call - AI Traction Fuels Seven-Figure Deals, ARR Expansion and $500M Army Agreement
Appian closed 2025 with accelerating AI-driven demand, larger deals, and steadily improving profitability. Q4 cloud subscription revenue rose 18% to $117.0 million, total revenue jumped 22% to $202.9 ...
- Q4 2025 cloud subscription revenue grew 18% year-over-year to $117.0 million; total revenue grew 22% to $202.9 million.
- Full year 2025 cloud subscription revenue rose 19% to $437.4 million; full year total revenue grew 18% to $726.9 million; adjusted EBITDA for 2025 was $76.8 million.
- Appian reported Q4 adjusted EBITDA of $19.7 million, ahead of guidance of $10–$13 million, and non-GAAP net income of $11.1 million, or $0.15 per diluted share.
- +15 more takeaways
Garrett Motion Q4 2025 Earnings Call - Trane partnership validates e-cooling ramp, industrial cooling to exceed 5% of revenue by 2030
Garrett closed 2025 with solid core performance and a clear strategic pivot into industrial cooling and e-powertrain technologies. Full year net sales were $3.58 billion, adjusted EBIT $510 million (1...
- Q4 2025 net sales were $891 million, adjusted EBIT $122 million, with a 13.7% margin; full year net sales $3.58 billion and adjusted EBIT $510 million, 14.2% margin.
- Adjusted free cash flow for 2025 was $403 million, implying roughly 80% free cash flow conversion for the year.
- Garrett repaid $50 million of its term loan in 2025, repurchased $208 million of common stock (including $72 million in Q4), paid $52 million in dividends, and ended the year with liquidity of $807 million.
- +13 more takeaways
Praxis Precision Medicines Fourth Quarter and Full Year 2025 Earnings Call - Two NDAs Filed, Poised to Transition to a Commercial Company
Praxis closed 2025 with a fast, high-stakes pivot: two NDAs submitted—ulixacaltamide for essential tremor and relutrigine for SCN2A and SCN8A DEEs—while juggling multiple near-term readouts and launch...
- Praxis submitted two NDAs: ulixacaltamide for essential tremor and relutrigine for SCN2A and SCN8A developmental and epileptic encephalopathies (DEEs).
- Ulixacaltamide received FDA Breakthrough Therapy designation in December after positive Essential3 results that met primary and key secondary endpoints, and the NDA is now filed.
- Relutrigine NDA for SCN2A and SCN8A DEEs has been submitted; the drug has Rare Pediatric Disease Designation and could be eligible for a Pediatric Review Voucher if approved.
- +12 more takeaways
Laureate Education Fourth Quarter and Fiscal Year 2025 Earnings Call - Historic 30.5% Adjusted EBITDA Margin, Net Cash and $150M Buyback Increase
Laureate closed FY2025 with strong top-line growth and margins, reporting $1.702 billion in revenue and a record adjusted EBITDA margin of 30.5% (Adjusted EBITDA $519 million). The company finished th...
- FY2025 revenue $1.702 billion, Adjusted EBITDA $519 million, delivering a record adjusted EBITDA margin of 30.5%.
- Q4 2025: revenue $541 million, Adjusted EBITDA $204 million; reported net income $172 million, GAAP EPS $1.17, adjusted net income $112 million, adjusted EPS $0.76 (up 46% YoY).
- Full-year GAAP net income $284 million, GAAP EPS $1.89; adjusted net income $256 million, adjusted EPS $1.72 (up 22% YoY).
- +16 more takeaways